Cargando…

Machine learning on large scale perturbation screens for SARS-CoV-2 host factors identifies β-catenin/CBP inhibitor PRI-724 as a potent antiviral

Expanding antiviral treatment options against SARS-CoV-2 remains crucial as the virus evolves under selection pressure which already led to the emergence of several drug resistant strains. Broad spectrum host-directed antivirals (HDA) are promising therapeutic options, however the robust identificat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Kelch, Maximilian A., Vera-Guapi, Antonella, Beder, Thomas, Oswald, Marcus, Hiemisch, Alicia, Beil, Nina, Wajda, Piotr, Ciesek, Sandra, Erfle, Holger, Toptan, Tuna, Koenig, Rainer
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Microbiology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10277617/ https://www.ncbi.nlm.nih.gov/pubmed/37342561 http://dx.doi.org/10.3389/fmicb.2023.1193320

Ejemplares similares

Targeting of Deregulated Wnt/β-Catenin Signaling by PRI-724 and LGK974 Inhibitors in Germ Cell Tumor Cell Lines
por: Schmidtova, Silvia, et al.
Publicado: (2021)

Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells
por: Kleszcz, Robert, et al.
Publicado: (2023)

Safety, Tolerability, and Preliminary Efficacy of the Anti-Fibrotic Small Molecule PRI-724, a CBP/β-Catenin Inhibitor, in Patients with Hepatitis C Virus-related Cirrhosis: A Single-Center, Open-Label, Dose Escalation Phase 1 Trial
por: Kimura, Kiminori, et al.
Publicado: (2017)

Safety, tolerability, and anti-fibrotic efficacy of the CBP/β-catenin inhibitor PRI-724 in patients with hepatitis C and B virus-induced liver cirrhosis: An investigator-initiated, open-label, non-randomised, multicentre, phase 1/2a study
por: Kimura, Kiminori, et al.
Publicado: (2022)

Molecular Analyses of Clinical Isolates and Recombinant SARS-CoV-2 Carrying B.1 and B.1.617.2 Spike Mutations Suggest a Potential Role of Non-Spike Mutations in Infection Kinetics
por: Veleanu, Andrei, et al.
Publicado: (2022)

The Transcriptional Coactivator Cbp Interacts with β-Catenin to Activate Gene Expression
por: Takemaru, Ken-Ichi, et al.
Publicado: (2000)

Differentiation Therapy Targeting the β-Catenin/CBP Interaction in Pancreatic Cancer
por: Manegold, Philipp, et al.
Publicado: (2018)

CBP/Catenin Antagonist Safely Eliminates Drug Resistant Leukemia Initiating Cells
por: Zhao, Yi, et al.
Publicado: (2015)

Inhibition of CBP/β‐catenin signaling ameliorated fibrosis in cholestatic liver disease
por: Kimura, Masamichi, et al.
Publicado: (2022)

Adiós al PRI /
por: Zaid, Gabriel
Publicado: (1995)

Wnt3a/β-Catenin/CBP Activation in the Progression of Cervical Intraepithelial Neoplasia
por: Feng, Dingqing, et al.
Publicado: (2021)

Determination of serum CA724 levels using fluorescence immunochromatography
por: Liu, Chang, et al.
Publicado: (2023)

Serum CA724 has no diagnostic value for gastrointestinal tumors
por: Cao, Huiru, et al.
Publicado: (2023)

Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?
por: Toptan, Tuna, et al.
Publicado: (2021)

Low But Recoverable Markers of Humoral Immune Response to BNT162b2 in Elderly LTCF Residents Five to Seven Months After Two-Dose Vaccination
por: Delbrück, Marla, et al.
Publicado: (2022)

Targeting the CBP/β-Catenin Interaction to Suppress Activation of Cancer-Promoting Pancreatic Stellate Cells
por: Che, Mingtian, et al.
Publicado: (2020)

What "Panel-Prying" Really Is
Publicado: (1921)

Structural Insight into the DNA-Binding Mode of the Primosomal Proteins PriA, PriB, and DnaT
por: Huang, Yen-Hua, et al.
Publicado: (2014)

Identification of genetic interactions with priB links the PriA/PriB DNA replication restart pathway to double-strand DNA break repair in Escherichia coli
por: McKenzie, Aidan M, et al.
Publicado: (2022)

Small molecule inhibition of CBP/catenin interactions eliminates drug resistant clones in acute lymphoblastic leukemia
por: Gang, Eun Ji, et al.
Publicado: (2013)

Effect of inhibition of CBP-coactivated β-catenin-mediated Wnt signalling in uremic rats with vascular calcifications
por: Gravesen, Eva, et al.
Publicado: (2018)

CBP/β-Catenin/FOXM1 Is a Novel Therapeutic Target in Triple Negative Breast Cancer
por: Ring, Alexander, et al.
Publicado: (2018)

El PRI y sus antepasados
por: Lajous, Alejandra
Publicado: (1982)

The Importance of PRI Therapy for the Pastoral Counsellor
por: Bisschops, Anke
Publicado: (2009)

DGCR8-dependent efficient pri-miRNA processing of human pri-miR-9-2
por: Nogami, Masahiro, et al.
Publicado: (2021)

Vitamin D Compounds PRI-2191 and PRI-2205 Enhance Anastrozole Activity in Human Breast Cancer Models
por: Filip-Psurska, Beata, et al.
Publicado: (2021)

Pri-miR526b and Pri-miR655 Are Potential Blood Biomarkers for Breast Cancer
por: Majumder, Mousumi, et al.
Publicado: (2021)

PT724. Prevalence and Factors related to Medication Adherence in Chronic Psychiatric Disorder
por: Ihm, H.K., et al.
Publicado: (2016)

Spatial distribution characteristics of tumor marker CA724 reference values in China
por: Jing, Jing, et al.
Publicado: (2019)

724. The In Vitro Activity of Gepotidacin and Comparator Agents Against Anaerobic Bacterial Isolates
por: Hackel, Meredith, et al.
Publicado: (2019)

SAT-724 Endocrine Disruption by Phthalate Exposure in the Pediatric Intensive Care Unit
por: Jacobs, An, et al.
Publicado: (2020)

Study on the Differential Value of Tumor Marker CA724 on Primary Gastric Cancer
por: Ding, Jieying, et al.
Publicado: (2021)

Afatinib as a Potential Therapeutic Option for Patients With NSCLC With EGFR G724S
por: Wei, Yang, et al.
Publicado: (2021)

Essential gene prediction in Drosophila melanogaster using machine learning approaches based on sequence and functional features
por: Aromolaran, Olufemi, et al.
Publicado: (2020)

Nuclear receptor/Wnt beta-catenin interactions are regulated via differential CBP/p300 coactivator usage
por: Ono, Masaya, et al.
Publicado: (2018)

Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer
por: Kartha, Vinay K., et al.
Publicado: (2018)

The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner
por: Wiese, Maria, et al.
Publicado: (2017)

Inhibition of β‐catenin/CBP signalling improves airway epithelial barrier function and suppresses CCL20 release
por: Kuchibhotla, Virinchi N. S., et al.
Publicado: (2020)

CBP-mediated Wnt3a/β-catenin signaling promotes cervical oncogenesis initiated by Piwil2
por: Feng, Dingqing, et al.
Publicado: (2020)

Optimized qRT-PCR Approach for the Detection of Intra- and Extra-Cellular SARS-CoV-2 RNAs
por: Toptan, Tuna, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_1c20jvnvtouvdgkir0ii0kk3t6